Dr. Célia Maschi

Dr. Célia Maschi

Ocular oncologist

Dr. Célia Maschi is an ophthalmologist specializing in ocular oncology and holds an interuniversity diploma in ocular oncology. She provides dedicated consultations for suspicious eye lesions and performs surgical procedures for patients with intraocular and ocular surface tumors.

Short Bio

After six years of medical studies at the University of Nice Sophia-Antipolis, Dr. Célia Maschi chose ophthalmology as her specialty at the Nice University Hospital following the National Ranking Examination. She quickly developed an interest in ocular oncology, a field in which the Nice University Hospital is recognized at both national and international levels, and trained under Dr. Caujolle. She obtained the Interuniversity Diploma in Ocular Oncology in 2010 from Claude Bernard University in Lyon. Her current hospital practice focuses on the management and follow-up of patients with ocular cancer, and she is particularly involved in clinical research through both industrial and academic projects.

Career path

  • Medical Degree (2000–2011) – University of Nice Sophia-Antipolis, Nice, France
  • University Hospital Clinical Lecturer (2011–2013) – Nice University Hospital, Nice, France
  • Part-time Hospital Practitioner (2013–present) – Nice University Hospital, Nice, France
  • Private Practice Ophthalmologist (2013–present) – Nice, France

Education

  • Master’s Degree, Life Sciences (Master 1) (2002) – University of Nice Sophia-Antipolis, Nice, France
  • Interuniversity Diploma (DIU) in Ocular Inflammation and Infection (2008) – Paris Diderot University, Paris, France
  • University Diploma (DU) in Retinal Imaging and Retinal Diseases (2010) – Paris Diderot University, Paris, France
  • Interuniversity Diploma (DIU) in Ocular Oncology (2010) – Claude Bernard University, Lyon, France
  • Interuniversity Diploma (DIU) in Vitreoretinal Surgery (2012) – University of Lorraine, Nancy, France

Publications

Publications: 50
Citations: 902 by 716 publications
h-index: 17
ORCID: https://orcid.org/0000-0002-9424-1539

  • Dubar P, Mathis T, Hucteau E, Thariat J, Nhari M, Maschi C, Faber C, Kiilgaard JF, Mosci C, Favard C, Tick S, Nguyen AM, Caujolle JP, Delyfer MN, Rosier L. A fast protocol for photodynamic therapy in exudative choroidal circumscribed hemangioma: Early laser irradiance after end of verteporfin infusion. Acta Ophthalmol. Published online May 5, 2025. doi:10.1111/aos.17513
  • Marin L, Toumi E, Caujolle JP, Doyen J, Martel A, Nahon-Esteve S, Maschi C, Baillif S. OCT-angiography for the diagnosis of radiation maculopathy in patients treated with proton beam therapy: A 2-year prospective study. Eur J Ophthalmol. 2022;32(5):3035-3042. doi:10.1177/11206721211067331
  • Mathis T, Maschi C, Mosci C, Espensen CA, Rosier L, Favard C, Tick S, Remignon CH, Ligorio P, Bonin N, Gambrelle J, Nguyen AM, Faber C, Meyer L, Mouriaux F, Herault J, Baillif S, Kiilgaard JF, Kodjikian L, Caujolle JP, Salleron J, Thariat J. COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA. Retina. 2021;41(2):277-286. doi:10.1097/IAE.0000000000002843
  • Thariat J, Salleron J, Maschi C, Fevrier E, Lassalle S, Gastaud L, Baillif S, Claren A, Baumard F, Herault J, Caujolle JP. Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas. Radiat Oncol. 2019;14(1):239. doi:10.1186/s13014-019-1426-6
  • Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle JP. Management of Invasive Squamous Cell Carcinomas of the Conjunctiva. Am J Ophthalmol. 2019;200:1-9. doi:10.1016/j.ajo.2018.11.024

Publication list